The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
976
June 7, 1996
View Complete Issue         Table of Contents 2019 
Issue 976
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Clarithromycin and Omeprazole for Helicobacter Pylori
June 7, 1996 (Issue: 976)
The US Food and Drug Administration (FDA) recently approved the marketing of clarithromycin (Biaxin - Abbott), a macrolide antibiotic, and omeprazole (Prilosec - Astra Merck), a proton pump inhibitor, for concurrent use in treatment of duodenal...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 976
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.